Elikya Therapeutics

Private

StrasbourgHealthcare & Life Scienceshttps://www.elikya-therapeutics.com/

Company Overview

Elikya Therapeutics is a biotechnology company that develops next-generation antibody-drug conjugates (ADCs) with first-in-class toxic payloads for oncology treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCtoxic payloadsoncology therapeuticsintra-tumoral therapycancer drug discoverybiotech licensingtargeted cancer therapypreclinical developmentdrug resistancecytotoxic drugsnext-gen biologicsprecision oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elikya Therapeutics Comparables

Compare Elikya Therapeutics with similar companies based on industry and business-model similarity.

Elikya Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Eli Lilly and Company	82%
Phrontline Biopharma	81%
Byondis	79%

View all Comparables

Elikya Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Gary Brandam

Co-founder & CEO

Founding Team

Elikya Therapeutics Investors

Notable investors and investment history

Elikya Therapeutics investors
Investor	Rounds
Landmark BioVentures AG	Seed
SEMIA	Seed
SATT Paris-Saclay	Seed
Bpifrance	Grant

View all Investors

Elikya Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Elikya Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elikya Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg

Employee Range2

Year Founded2021

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.